journal article
Open Access
Aug 28, 2021
Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management
Abstract
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases that are characterized by widespread epidermal necrosis and sloughing of skin. They are associated with significant morbidity and mortality, and early diagnosis and treatment is critical in achieving favorable outcomes for patients. In this scoping review, Excerpta Medica dataBASE and PubMed were searched for publications that addressed recent advances in the diagnosis and management of the disease. Multiple proteins (galectin 7 and RIP3) were identified that are promising potential biomarkers for SJS/TEN, although both are still in early phases of research. Regarding treatment, cyclosporine is the most effective therapy for the treatment of SJS, and a combination of intravenous immunoglobulin (IVIg) and corticosteroids is most effective for SJS/TEN overlap and TEN. Due to the rare nature of the disease, there is a lack of prospective, randomized controlled trials and conducting these in the future would provide valuable insights into the management of this disease.
Topics
No keywords indexed for this article. Browse by subject →
References
94
[1]
Duong "Severe cutaneous adverse reactions to drugs" Lancet (2017) 10.1016/s0140-6736(16)30378-6
[2]
Frey "The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK" J. Investig. Dermatol. (2017) 10.1016/j.jid.2017.01.031
[3]
Hsu "Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults" J. Investig. Dermatol. (2016) 10.1016/j.jid.2016.03.023
[4]
Yang, M.-S., Lee, J.Y., Kim, J., Kim, G.-W., Kim, B.-K., Kim, J.-Y., Park, H.-W., Cho, S.-H., Min, K.-U., and Kang, H.-R. (2016). Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. PLoS ONE, 11.
10.1371/journal.pone.0165933
[5]
Hsu "Pediatric Stevens-Johnson syndrome and toxic epidermal necroly-sis in the United States" J. Am. Acad. Dermatol. (2017) 10.1016/j.jaad.2016.12.024
[6]
Paulmann "Severe skin reactions: Clinical picture, epidemiology, etiology, pathogenesis, and treatment" Allergo J. Int. (2019) 10.1007/s40629-019-00111-8
[7]
Lim "A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness" Burns (2016) 10.1016/j.burns.2016.01.014
[8]
Lissia "Toxic epidermal necrolysis (Lyell’s disease)" Burns (2010) 10.1016/j.burns.2009.06.213
[9]
Richer "Acute blistering diseases on the burn ward: Beyond Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis" Burns (2013) 10.1016/j.burns.2013.02.009
[10]
Sekula "Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis" J. Investig. Dermatol. (2013) 10.1038/jid.2012.510
[11]
Paggiaro "The Role of Biological Skin Substitutes in Ste-vens-Johnson Syndrome: Systematic Review" Plast. Surg. Nurs. Off. J. Am. Soc. Plast. Reconstr. Surg. Nurses (2018)
[12]
Charlton "Toxic Epidermal Necrolysis and Steven-Johnson Syn-drome: A Comprehensive Review" Adv. Wound Care (2020) 10.1089/wound.2019.0977
[13]
Guvenir "Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions" Curr. Pharm. Des. (2019) 10.2174/1381612825666191107162921
[14]
Paulmann "Fever in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases" Pediatr. Infect. Dis. J. (2017) 10.1097/inf.0000000000001571
[15]
Alerhand "Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Popula-tion: A Review" Pediatric Emerg. Care (2016) 10.1097/pec.0000000000000840
[16]
Mockenhaupt "Erythema multiforme, Stevens-Johnson syndrome/Toxic Epidermal Necrolysis—Diagnosis and treatment" JDDG J. Ger. Soc. Dermatol. (2020)
[17]
Shanbhag, S., Chodosh, J., Fathy, C., Goverman, J., Mitchell, C., and Saeed, H.N. (2020). Multidisciplinary care in Stevens-Johnson syndrome. Ther. Adv. Chronic Dis., 11.
10.1177/2040622319894469
[18]
Basu "Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease" Am. J. Ophthalmol. (2018) 10.1016/j.ajo.2018.01.028
[19]
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome
Darren G. Gregory
Ophthalmology
2016
10.1016/j.ophtha.2016.04.041
[20]
Aghdam "Toxic epidermal necrolysis syndrome following single-dose diclofenac suppos-itory, a case report" J. Compr. Pediatrics (2020)
[21]
Alajmi "A pediatric case of Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with rap-id response to intravenous cyclosporine" JAAD Case Rep. (2020) 10.1016/j.jdcr.2020.04.003
[22]
Maloney "Stevens-Johnson syndrome and Toxic Epidermal Necrolysis-like reac-tions to checkpoint inhibitors: A systematic review" Int. J. Dermatol. (2020) 10.1111/ijd.14811
[23]
Simonsen "Cutaneous adverse reactions to anti–PD-1 treatment—A systematic review" J. Am. Acad. Dermatol. (2020) 10.1016/j.jaad.2020.04.058
[24]
Madabhavi "Toxic epidermal necrolysis with the use of tamoxifen" BMJ Case Rep. (2015) 10.1136/bcr-2014-209102
[25]
Mani "Rashes and other hypersensitivity reactions associ-ated with antiepileptic drugs: A review of current literature" Seizure (2019) 10.1016/j.seizure.2019.07.015
[26]
Rashid "Valproic acid and Stevens-Johnson syndrome: A systematic review of descriptive studies" Int. J. Dermatol. (2019) 10.1111/ijd.14411
[27]
Gupta "Allopurinol-Induced Stevens-Johnson Syndrome" Am. J. Med. Sci. (2019) 10.1016/j.amjms.2018.11.018
[28]
Sibbald "Retrospective review of drug-induced Stevens-Johnson syn-drome and Toxic Epidermal Necrolysis cases at a pediatric tertiary care institution" Pediatric Dermatol. (2020) 10.1111/pde.14118
[29]
Sassolas "ALDEN, an algorithm for assessment of drug causal-ity in stevens-johnson syndrome and Toxic Epidermal Necrolysis: Comparison with case-control analysis" Clin. Pharmacol. Ther. (2010) 10.1038/clpt.2009.252
[30]
Hasegawa "Recent advances in managing and understanding Stevens-Johnson syndrome and Toxic Epidermal Necrolysis" F1000Research (2020) 10.12688/f1000research.24748.1
[31]
Abe "Immunological response in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis" J. Dermatol. (2015) 10.1111/1346-8138.12674
[32]
Adam "Delayed drug hypersensitivity: Models of T-cell stimulation" Br. J. Clin. Pharmacol. (2010) 10.1111/j.1365-2125.2010.03764.x
[33]
Pichler "Modes of presentation of chemical neoantigens to the immune system" Toxicology (2002) 10.1016/s0300-483x(02)00254-8
[34]
Abe "Toxic epidermal necrolysis and Stevens-Johnson syn-drome are induced by soluble fas ligand" Am. J. Pathol. (2003) 10.1016/s0002-9440(10)64284-8
[35]
Chung "Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis" Nat. Med. (2008) 10.1038/nm.1884
[36]
Chen "Detecting Lesional Granulysin Levels for Rapid Di-agnosis of Cytotoxic T lymphocyte–Mediated Bullous Skin Disorders" J. Allergy Clin. Immunol. Pract. (2020) 10.1016/j.jaip.2020.09.048
[37]
Abe "Granulysin as a marker for early diagnosis of the Stevens-Johnson syn-drome" Ann. Intern. Med. (2009) 10.7326/0003-4819-151-7-200910060-00016
[38]
Saito "Prolonged elevation of serum granulysin in drug-induced hy-persensitivity syndrome" Br. J. Dermatol. (2012) 10.1111/j.1365-2133.2012.10921.x
[39]
Su "Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis" J. Investig. Dermatol. (2017) 10.1016/j.jid.2016.11.034
[40]
Hasegawa "019 Serum RIP3 level as a severi-ty-predictive marker for Stevens-Johnson syndrome and Toxic Epidermal Necrolysis" J. Investig. Dermatol. (2019) 10.1016/j.jid.2019.03.095
[41]
Hasegawa "RIP3 as a diagnostic and severity marker for Stevens-Johnson syndrome and Toxic Epidermal Necrolysis" J. Allergy Clin. Immunol. Pract. (2020) 10.1016/j.jaip.2020.01.006
[42]
Saito "An annexin A1-FPR1 interaction contributes to necrop-tosis of keratinocytes in severe cutaneous adverse drug reactions" Sci. Transl. Med. (2014) 10.1126/scitranslmed.3008227
[43]
Abate "Dermatologic Urgencies and Emergencies: What Every Pathologist Should Know" Arch. Pathol. Lab. Med. (2019) 10.5858/arpa.2018-0239-ra
[44]
Kerl "Severe cutaneous adverse drug reactions" Diagn. Histopathol. (2020) 10.1016/j.mpdhp.2020.10.008
[45]
Lin "Stevens-Johnson syndrome and Toxic Epidermal Necrolysis: Risk factors, causality assessment and potential prevention strategies" Expert Rev. Clin. Immunol. (2020) 10.1080/1744666x.2020.1740591
[46]
LeCleach "Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?" Arch. Dermatol. (2000)
[47]
Cavkaytar "An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions" Curr. Pharm. Des. (2019) 10.2174/1381612825666191106115556
[48]
Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
Ruairi M. Gallagher, Jamie J. Kirkham, Jennifer R. Mason et al.
PLoS ONE
10.1371/journal.pone.0028096
[49]
Coias "Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Review and Update" Curr. Dermatol. Rep. (2019) 10.1007/s13671-019-00275-0
[50]
Hu "SCORTEN and impaired renal function related to mortality of Toxic Epidermal Necrolysis syndrome patients in the Asian population" J. Eur. Acad. Dermatol. Venereol. (2012) 10.1111/j.1468-3083.2012.04502.x
Showing 50 of 94 references
Cited By
171
Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review
Ophthalmology and Therapy
Gábor Tóth, Andrea Lukács · 2023
Metrics
171
Citations
94
References
Details
- Published
- Aug 28, 2021
- Vol/Issue
- 57(9)
- Pages
- 895
- License
- View
Authors
Cite This Article
Robert Frantz, Simo Huang, Abhirup Are, et al. (2021). Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. Medicina, 57(9), 895. https://doi.org/10.3390/medicina57090895
Related
You May Also Like
Foundational Statistical Principles in Medical Research: Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value
Thomas F. Monaghan, Syed N. Rahman · 2021
345 citations
Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective
Raffaele Pezzani, Bahare Salehi · 2019
209 citations